Mitochondria and Diabetes


There is strong evidence of involvement of mitochondria in type 2 diabetes, causing or caused by insulin resistance of muscle, insulin secretion from the pancreas and in the complications of diabetes. Typically, the number and size of mitochondria is reduced in the muscle of diabetics, there is reduced mitochondrial biogenesis and switching of metabolic substrate use that is linked directly to mitochondrial enzymes. Insulin secretion from the pancreatic islet cells requires ATP and altered functioning of mitochondria and the resulting increased oxidative stress of these cells is thought to play a major part in the reduced insulin release.

Among the most convincing links between mitochondrial dysfunction and diabetes are the observed diabetic pathology of a point mutation in mtDNA encoding the tRNA for leucine, and the more recent finding that depletion of the mitochondrial nicotinamide nucleotide transhydrogenase (NNT) caused much reduced insulin secretion from islet cells.


Monoclonal Antibodies
Cat. No. Name Reactivity Apps. Amount Price  
MS701 NNT antibody human, bovine, mouse, rat WB, ICC, IHC, IP, ICE 100 µg $325.00


In-Cell ELISA Assays
Cat. No. Name Reactivity Amount Price  
MS642 MitoBiogenesis™ In-Cell ELISA Kit (IR) human, rat, mouse, bovine 2 x 96 tests $425.00
MS643 MitoBiogenesis™ In-Cell ELISA Kit (Colorimetric) human, rat, mouse, bovine 2 x 96 tests $425.00


Protein Quantity Assays
Cat. No. Name Reactivity Amount Price  
MSFX-8 NNT FlexPlex™ Module human 4 strips (32 tests) $125.00



Browse Products By:
Product Search:




Subscribe to MitoNews
MitoNews is a free periodic annotated review of important publications in mitochondria and metabolic research.

MitoNews Latest Issue
Volume 10 Issue 02 (July 2014)

MitoNews Archives




Sales & Customer Support:
1-888-772-2226

us.orders@abcam.com

© 2004-2013 MitoSciences Inc, an Abcam company. All rights reserved.